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APACHE II Score, Rather Than Cardiac Function, May Predict 
Poor Prognosis in Patients With Stress-Induced Cardiomyopathy 
While the disease course of stress-induced cardiomyopathy (SIC) is usually benign, it can be 
fatal. The prognostic factors to predict poorer outcome are not well established, however. 
We analyzed the Acute Physiology And Chronic Health Evaluation (APACHE) II score to 
assess its value for predicting poor prognosis in patients with SIC. Thirty-seven consecutive 
patients with SIC were followed prospectively during their hospitalization. Clinical factors, 
including APACHE II score, coronary angiogram, echocardiography and cardiac enzymes at 
presentation were analyzed. Of the 37 patients, 27 patients (73%) were women. The mean 
age was 66.1 ± 15.6 yr, and the most common presentation was chest pain (38%). Initial 
echocardiographic left ventricular ejection fraction (EF) was 42.5% ± 9.3%, and the wall 
motion score index (WMSI) was 1.9 ± 0.3. Six patients (16%) expired during the follow-up 
period of hospitalization. Based on the analysis of characteristics and clinical factors, the 
only predictable variable in prognosis was APACHE II score. The patients with APACHE II 
score greater than 20 had tendency to expire than the others (P = 0.001). Based on present 
study, APACHE II score more than 20, rather than cardiac function, is associated with 
mortality in patients with SIC.
Key Words: APACHE II Score; Cardiac Function; Stress-Induced Cardiomyopathy
Byung-Hyun Joe
1, Uk Jo
1, Hyun-Soo Kim
1, 
Chang-Bum Park
1, Hui-Jeong Hwang
1, 
Il-Suk Sohn
1, Eun-Sun Jin
1, Jin-Man Cho
1, 
Jeong-Hwan Park
2, and Chong-Jin Kim
1
1Department of Internal Medicine, Kyung-Hee 
University, School of Medicine, Seoul; 
2Department 
of Cardiology, Incheon Sarang Hospital, Inchon, 
Korea
Received: 11 July 2011
Accepted: 7 November 2011
Address for Correspondence:
Chong-Jin Kim, MD
Department of Internal Medicine, Kyung-Hee University, School 
of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 
130-701, Korea
Tel: +82.2-440-6106, Fax: +82.2-442-6638
E-mail: chongjinkim0316@yahoo.co.kr
http://dx.doi.org/10.3346/jkms.2012.27.1.52  •  J Korean Med Sci 2012; 27: 52-57
ORIGINAL ARTICLE
Cardiovascular Disorders
INTRODUCTION
Stress-induced cardiomyopathy (SIC) typically presents as tran-
sient cardiac dysfunction with unique apical ballooning (1). 
Management is generally supportive, and, because the cardiac 
dysfunction at presentation is almost transient and reversible,  
it is reasonably treated with standard medication for left ventric-
ular systolic dysfunction (2). Although the prognosis for SIC is 
usually favorable, it can be fatal in up to 8% of hospitalized cases 
(3-6). In spite of the possibility of death, little effort has been made 
to identify predictive factors for poor prognosis in SIC. 
  The Acute Physiology And Chronic Health Evaluation (APA-
CHE) II score is a well-known disease severity index for hospi-
talized adults that has a solid relationship with predicting the 
mortality of critically ill patients (7). We analyzed the value of 
the APACHE II score for predicting poor prognosis in hospital-
ized patients with SIC.
MATERIALS AND METHODS
Study patients
Between June 2006 and October 2010, 3,100 patients were seen 
in our institutions with suspected acute coronary syndrome 
(ACS). Of these, 37 patients fulfilled the following criteria (1, 8) 
for SIC: 1) older than 18 yr; 2) transient akinesia/dyskinesia be-
yond a single major coronary artery vascular distribution; 3) 
absence of significant coronary artery disease upon coronary 
angiogram (CAG) and 4) the presence of definite antecedent 
physical or mental trigger factors, identified by the attending 
physicians. No patients had a preexisting cardiomyopathy, in-
tracranial bleeding, or pheochromocytoma. We applied ergo-
novine echocardiography to all patients diagnosed with SIC to 
rule out coronary vasospasm within two days after CAG, and 
there was no patient with positive finding on the test.
Clinical assessment
We reviewed medical records for chief complaint, smoking his-
tory, and co-morbidities. We also investigated the presence of 
physical stress (septic shock, surgery, or intubation, etc.) or men-
tal stress (anger management issues, death of loved one, or in-
terpersonal conflicts, etc.). Body mass index (BMI), level of car-
diac enzymes (creatine kinase MB fraction, CK-MB; troponin-I), 
high sensitive C-reactive protein (hsCRP), systolic and diastolic 
blood pressure (BP), heart rate (HR), and Killip class were eval-
uated at the time of diagnosis for SIC. 
  Standardized electrocardiography (ECG) and echocardio-
graphic studies were examined at the time of diagnosis and one 
or two weeks later to confirm the status of recovery. If regional 
wall motion abnormality (RWMA), observed on the first echo-
cardiogram, was not definitely improved on the second one, a Joe B-H, et al.  •  APACHE II Score in Stress-induced Cardiomyopathy
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third echocardiogram was performed a few weeks after the sec-
ond one. All patients showed resolution of RWMA. In echocar-
diography studies, we measured the left ventricular ejection frac-
tion (LVEF) and regional wall motion score index (WMSI) to de-
termine the severity of cardiac dysfunction. The LVEF was mea-
sured using the modified Simpson’s method, and WMSI was 
calculated using all views, including the parasternal short axis 
and long axis and apical four chamber views. We classified ven-
tricular ballooning into two categories, typical and atypical api-
cal ballooning, based on the location of ballooning. Standard 
2-dimensional and Doppler echocardiography was performed 
using a 2.5 MHz transducer with harmonic imaging. We used a 
Philips iE33 system (Philips Medical Systems, USA) for patients 
admitted to the general ward and ViVid I (GE Ultrasound, Horten, 
Norway) for patients in the intensive care unit. We calculated 
the APACHE II score, with the worst physiologic parameters dur-
ing the first 24 hr after the event, to measure the clinical severity 
of each patient’s objective physical condition upon presentation. 
APACHE II is composed of vital signs, serum creatinine level, 
oxygen pressure in arterial blood gas analysis, blood acidity, de-
gree of leukocytosis, level of hematocrit, severity of electrolyte 
imbalance, Glasgow coma scale (GCS; representing patient men-
tal status), and age of patient, each recorded at the most severe 
level in 24 hr (7).
Statistical analysis
All statistical analyses were performed using SPSS software (ver-
sion 18.0, SPSS Inc, Chicago, IL, USA). Continuous variables were 
expressed as mean ± SD or mean with interquartile ranges. Fre-
quencies and percentages were used to describe categorical 
variables and were compared based on the result of ROC curve 
analysis with Fisher’s exact test. Continuous variables of the two 
groups (Group I and II, divided by APACHE II score 20) were 
analyzed and compared using the student T-test. To estimate 
the sensitivity and specificity of the APACHE II score for predict-
ing death, ROC curve analysis was done. Kaplan-Meier survival 
analysis was performed to estimate the mortality according to 
survival period. Statistical significance was defined as P < 0.05 
in all of the analyses. 
Ethics statement
The institutional review board of Kyung-Hee University Hospi-
tal approved the protocal of this prospective SIC registry (KH-
NMC IRB 2011-026). The data were retrospectively reviewed 
and informed consents were provided by all patients. 
RESULTS
Parameters associated with the outcome
To find out the variable which is able to predict the outcomes of 
patients exceedingly, we analyzed the baseline characteristics 
and the clinical factors of patients, including the cardiac func-
tions, in terms of LVEF and WMSI, cardiac enzymes, such as CK-
MB and TnI, and APACHE II score based on survival (Table 1). 
And we figured out that APACHE II score was significantly differ-
ent between the dead and the survived among multiple clinical 
variables (22.5 ± 1.6 vs 11.7 ± 6.2, P value = 0.001). Even though 
SIC is a kind of cardiomyopathy, the abnormalities in ECG, the 
shape of apical ballooning, the heart functions and cardiac mark-
ers did not show any significant difference between two groups. 
And more male patients were included in the death group than 
survival group (67% vs 19%, P value = 0.035). Based on this re-
sult, we carried out receiver operating characteristics (ROC) 
curve analysis to confirm the availability of APACHE II score as 
a prognostic marker. According to the result of ROC curve anal-
ysis we divided the patients into group I (APACHE II score  > 20) 
and group II (APACHE II score  ≤ 20), because APACHE II score 
20 showed higher sensitivity and specificity than any other scores 
(Fig. 1). The comparison between group I and group II was done 
to find out any other clinical factors, which is related to the prog-
Table 1. The comparisons of characteristics and clinical factors based on survival
Parameters Survival (n = 31) Death (n = 6) P value
Age (yr)   65.4 ± 15.8   69.7 ± 15.6 0.546
Body mass index (kg/m
2) 21.5 ± 3.5 21.2 ± 3.2 0.850
Gender
   Male, No. (%)
   Female, No. (%)
 
  6 (19)
25 (81)
 
  4 (67)
  2 (33)
0.035
Smoking
   Never, No. (%)
   Current, No. (%)
 
27 (87)
  4 (13)
 
  4 (67)
  2 (33)
 
0.245
Stress type
   Physical, No. (%)
   Mental, No. (%)
 
25 (81)
  6 (19)
 
    6 (100)
0 (0)
0.561
Presenting symptoms/signs
   Chest pain, No. (%)
   Dyspnea, No. (%)
   Altered mentality, No. (%)
   Hypotension, No. (%)
 
13 (42)
  7 (23)
  5 (16)
  5 (16)
 
  1 (17)
  4 (67)
  1 (17)
0 (0)
0.258
Killip class
   Class I, No. (%)
   Class II, No. (%)
   Class III, No. (%)
   Class IV, No. (%)
 
22 (71)
  6 (19)
  3 (10)
0 (0)
 
  2 (34)
  3 (50)
  1 (17)
0 (0)
0.195
Electrocardiographic abnormalities
   T wave inversion, No. (%)
   ST elevation, No. (%)
   ST depression, No. (%)
 
14 (45)
  5 (16)
  5 (16)
 
  2 (34)
  1 (17)
0 (0)
0.470
Apical ballooning
   Typical, No. (%)
   Atypical, No. (%)
 
25 (81)
  6 (19)
 
    6 (100)
0 (0)
0.561
CK-MB (ng/mL)   16.7 ± 54.6   15.6 ± 25.5 0.961
Troponin-I (ng/mL)   3.3 ± 7.7   2.3 ± 3.3 0.761
hsCRP (mg/L)   33.8 ± 46.7 26.0 ± 0.0 0.877
APACHE II score 11.7 ± 6.2 22.5 ± 1.6 0.001
LVEF (%) 42.9 ± 9.5 40.5 ± 8.5 0.563
WMSI   1.8 ± 0.4   2.0 ± 0.3 0.244
Mean ± SD. CK-MB, creatine kinase-MB; hsCRP, high sensitive C-reactive protein; 
APACHE II, acute physiology and chronic health evaluation II; LVEF, left ventricular ejec-
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nosis, as described beneath.
Baseline characteristics
The baseline characteristics of patients are presented in Table 2. 
The mean age was 66.1 ± 15.6 yr old, and the mean BMI was 
21.5 ± 3.4 kg/m
2. Twenty-seven (73%) of 37 patients were female, 
and 31 (84%) were non-smokers. One third of the subjects had 
comorbidities, with cancer being most common (n = 6, 16%). 
Except for a few comorbidities, such as cancer or chronic obstruc-
tive pulmonary disease (COPD), most of them were not related 
to SIC itself. 
Clinical characteristics and factors associated with survival
The comparisons of clinical characteristics of the subjects are 
presented in Table 3. Physical stress, such as sepsis, surgery, or 
acidosis, was reported more often than mental stress in both 
groups (100% vs 0% in group I and 79% vs 21% in group II, respec-
tively). Even though not described in the tables, operation was 
largest number of physical stress, followed by severe pneumo-
nia, acute pyelonephritis, and acute exacerbation of COPD. And 
The most frequent initial symptom on presentation was chest 
pain (n = 14, 38%), followed by dyspnea, altered mentality and 
hypotension, with dyspnea in group I and chest pain in group  
II being the most common respectively. ECG on presentation 
showed no remarkable arrhythmia. Among ECG abnormalities, 
T wave inversion was most common (n = 16, 43%), followed by 
ST elevation and ST depression. Corrected QT interval (QTc) was 
prolonged at the time of diagnosis (485.3 ± 55.5 ms). Serum car-
diac enzymes were elevated in all patients, and were not statis-
tically different between groups. In the echocardiographic study 
at the time of diagnosis, mean LVEF was 42.5% ± 9.3%, and mean 
WMSI was 1.9 ± 0.3 and those are not significantly different be-
tween two groups (P value = 0.573 and 0.516, respectively). There 
was no significant difference in the proportion of typical balloon-
ing between groups, although all patients in group I had typical 
ballooning at presentation (100% vs 79%, P value = 0.305). ROC 
curve indicated a high sensitivity (100%) and specificity (94%) 
of the APACHE II score for predicting death, with a threshold 
score of greater than 20 (Fig. 1). The APACHE II score at diagno-
sis was significantly higher in group I as compared to group II 
(22.1 ± 1.6 vs 11.0 ± 5.9, P = 0.001). Among multiple components 
of the APACHE II score, only maximal heart rate and Glascow 
coma scale were higher in group I. Six in group I and no one in 
group II died during hospitalization, all with physical stress and 
4 of them were male (Table 4). Their mean APACHE II score and 
LVEF were 22.5 (range 21-25) and 40.5% (range 26%-49%), re-
spectively. Mean time to death from diagnosis was 25 days (range 
2-111 days). Kaplan-Meier survival curve shows significant dif-
ference in cumulative survival between two groups divided by 
APACHE II score 20 (Fig. 2). 
DISCUSSION
In this prospective observational study, we could identify a few 
findings, as follows. First, the most frequent symptom was chest 
pain. This observation, similar result with another study in Korea 
(9), suggests that SIC should be one of the differential diagnoses 
for chest pain in conjunction with ACS. Second, the prevalence 
of SIC was much higher in women than men, even though there 
is no proven study about the reason of this preponderance as-
sociated with gender. The last, in spite of its old name ‘broken 
heart syndrome’, the patients were more connected with physi-
cal stress than mental stress.
   We also found that the APACHE II score more than 20, rather 
than cardiac functions, was associated with mortality in patients 
Table 2. Baseline characteristics of patients
Parameters
Total  
(n = 37)
Group I  
(n = 8)
Group II  
(n = 29)
P value
Age (yr)   66.1 ± 15.6   68.5 ± 13.4   65.4 ± 16.3 0.627
Body mass index (kg/m
2) 21.5 ± 3.4 21.8 ± 3.1 21.4 ± 3.6 0.772
Female, No. (%) 27 (73)   4 (50) 23 (79) 0.174
Smoking
   Never, No. (%)
   Current, No. (%)
 
31 (84)
  6 (16)
 
  6 (75)
  2 (25)
 
25 (86)
  4 (15)
0.591
Comorbidities
   None, No. (%)
   Cancer, No. (%)
   Diabetes mellitus, 
      No. (%)
   COPD, No. (%)
   Hypertension, No. (%)
   Hyperthyroidism, No. (%)
   Liver cirrhosis, No. (%)
   ESRD, No. (%)
 
13 (35)
  6 (16)
3 (8)
3 (8)
2 (5)
1 (3)
1 (3)
1 (3)
 
  2 (25)
  2 (25)
  1 (13)
  1 (13)
0 (0)
0 (0)
  1 (13)
0 (0)
 
11 (38)
  4 (14)
2 (7)
2 (7)
2 (7)
1 (3)
0 (0)
1 (3)
0.815
Mean ± SD. COPD, chronic obstructive pulmonary disease; ESRD, end-stage renal 
disease.
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Fig. 1. ROC curve of APACHE II score in predicting death in patients with stress-in-
duced cardiomyopathy. Joe B-H, et al.  •  APACHE II Score in Stress-induced Cardiomyopathy
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Table 3. Clinical characteristics and comparisons of two groups divided by APACHE II score 20
Parameters Total (n = 37) Group I (n = 8) Group II (n = 29) P value
Stress type
   Physical, No. (%)
   Mental, No. (%)
 
31 (84)
  6 (16)
 
    8 (100)
0 (0)
 
23 (79)
  6 (21)
0.305
Presenting symptoms/signs
   Chest pain, No. (%)
   Dyspnea, No. (%)
   Altered mentality, No. (%)
   Hypotension, No. (%)
 
14 (38)
11 (30)
  6 (16)
  5 (14)
 
  1 (13) 
  4 (50) 
  1 (13)
  2 (25)
 
13 (45)
  7 (24)
  5 (17)
  3 (10)
0.496
Killip class
   Class I, No. (%)
   Class II, No. (%)
   Class III, No. (%)
   Class IV, No. (%)
 
24 (65)
  9 (24)
  4 (11)
0 (0)
  
  3 (38)
  4 (50)
  1 (13)
0 (0)
 
21 (72)
  5 (17)
  3 (10)
0 (0)
0.179
Electrocardiographic abnormalities
   T wave inversion, No. (%)
   ST elevation, No. (%)
   ST depression, No. (%)
 
16 (43)
  6 (16)
  5 (14)
 
  3 (38)
  1 (13)
  1 (13)
 
13 (45)
  5 (17)
  4 (14)
0.521
Corrected QT interval (ms)   485.3 ± 55.5   482.5 ± 68.8   486.0 ± 52.7 0.877
Cardiac enzymes
   CK-MB (ng/mL)
   Troponin-I (ng/mL)
   hsCRP (mg/L)
 
    16.5 ± 50.6
    3.2 ± 7.1
    33.1 ± 44.3
 
      49.2 ± 103.7
      6.8 ± 13.7
  26.0 ± 0.0 
 
      7.2 ± 11.3
    2.1 ± 3.5
    33.8 ± 46.7
  
0.290
0.368
0.877
Echocardiogram on diagnosis
   LVEF (%)
   WMSI
 
  42.5 ± 9.3
    1.9 ± 0.3
 
  40.9 ± 7.7 
    1.9 ± 0.3
 
  43.0 ± 9.7
    1.8 ± 0.4
 
0.573
0.516
Apical ballooning
   Typical, No. (%)
   Atypical, No. (%)
 
31 (84)
  6 (16)
 
    8 (100)
0 (0)
 
23 (79)
  6 (21)
0.305
APACHE II score   13.4 ± 7.0   22.1 ± 1.6   11.0 ± 5.9 0.001
Blood temperature (°C)   36.8 ± 0.6   36.7 ± 0.3   36.9 ± 0.6 0.403
Mean arterial blood pressure (mmHg)     81.9 ± 20.3     77.9 ± 23.5     83.0 ± 19.7 0.535
Maximum heart rate (rate/min)   106.2 ± 26.6   126.6 ± 16.9   100.6 ± 26.2 0.012
Maximum respiratory rate (rate/min)   25.7 ± 6.0   28.4 ± 6.8   24.9 ± 5.7 0.155
Oxygenation score     0.8 ± 1.2     1.0 ± 1.6     0.7 ± 1.1 0.536
Acidity score     0.8 ± 1.1     1.3 ± 1.3     0.7 ± 1.1 0.218
Serum sodium (mEq/L) 138.7 ± 4.7 137.9 ± 6.1 138.9 ± 4.4 0.596
Serum potassium (mEq/L)     3.8 ± 0.7     3.6 ± 0.6     3.8 ± 0.7 0.435
Serum creatinine (mg/dL)     1.2 ± 1.5     1.4 ± 0.8     1.2 ± 1.7 0.791
Kidney function score     0.6 ± 1.5     1.8 ± 2.5     0.2 ± 0.8 0.133
Leukocytes (/µL)   11,924.3 ± 5,196.1   11,400.0 ± 4,535.3   12,069.0 ± 5,428.8 0.752
Hematocrit (%)   32.3 ± 5.3   30.0 ± 3.6   32.9 ± 5.6 0.173
Glascow coma scale     2.2 ± 3.0     5.5 ± 3.5     1.3 ± 2.2 0.001
Age score     3.9 ± 2.1     4.4 ± 1.5     3.8 ± 2.3 0.379
Length of hospital stay from diagnosis (days)      17.1 ± 21.5     30.5 ± 35.9     13.3 ± 14.4 0.224
Death during hospitalization, No. (%)   6 (16)   6 (75) 0 (0) 0.001
Mean ± SD. APACHE II, acute physiology and chronic health evaluation II; CK-MB, creatine kinase-MB; hsCRP, high sensitive C-reactive protein; LVEF, left ventricular ejection 
fraction; WMSI, wall motion score index.
with SIC, even though there was no study which proposed any 
prognostic factors using any kind of scoring systems. Most of 
studies with SIC were about its epidemiology, and the studies, 
interested in prognostic factor, were focusing only to cardiac 
findings, such as EKG results or cardiac markers. Based on our 
results, we suggest that outcomes may depend more upon the 
physical conditions of the patients than the severity of the symp-
toms or signs of cardiac dysfunction.
  To the best of our knowledge, there have been few attempts 
to evaluate a scoring system, like the APACHE II, for patient phys-
ical condition and SIC prognosis. We hypothesized that the APA-
CHE II score would correlate with patient prognosis, particular-
ly mortality, and sought to identify other factors with prognostic 
value. After confirmation that APACHE II score on diagnosis 
was related to prognosis, we also found that an APACHE II score 
greater than 20 had a high sensitivity (100%) and specificity (94%) 
for predicting in-hospital death in patients with SIC (Fig. 1).
  Among the components of the APACHE II score, maximal 
heart rate and GCS (a marker of consciousness regardless of ino-
tropic or sedative use) were increased more in patients who had Joe B-H, et al.  •  APACHE II Score in Stress-induced Cardiomyopathy
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APACHE II score greater than 20. ECG could potentially offer 
information about the prognosis of SIC patients. Our findings 
were in agreement with previous research, however, showing 
no link between electrocardiographic abnormalities and poor 
outcome (10). Overall, we saw that the prevalence of SIC was 
higher in females, as expected (1, 4, 6). 
  There are a few limitations in our study. Despite the prospec-
tive enrollment of SIC patients, we could only offer a single cen-
ter experience with a relatively small number of subjects, which 
was inevitable due to the low prevalence of SIC. Above this, we 
could not measure the relation between stress and prognosis, 
because there was no proven method for quantitative analysis 
of the physical and mental stress. And the cardiac functions were 
not evaluated with echocardiography in daily routine follow-up 
and at the time of death, nevertheless Lee et al. (11). suggested 
that the absence of left ventricular function recovery within a 
week could predict the poor outcome of patients. And the fol-
low-up echocardiography was not done at right time, because 
of many reasons concerned with their refusals, short hospital-
ization and cost problems.
Table 4. Clinical characteristics of the dead patients
Patients Gender Age Smoking Comorbidities Trigger (stress)
Killip class 
on  
diagnosis
LVEF (%)
APACHE II 
score
Time to 
death  
after diag-
nosis (days) 
Case 1 Male 47 Never None Infectious colitis I 49 25     6
Case 2 Male 71 Never Liver cirrhosis Hepatic encephalopathy III 46 21   14
Case 3 Male 73 Current COPD Acute exacerbation of COPD II 26 22 111
Case 4 Female 92 Current Lung cancer Lung cancer I 40 21     8
Case 5 Male 77 Never None Hospital acquired pneumonia II 46 24     9
Case 6 Female 58 Never Breast cancer Breast cancer with  
multiple metastasis
II 36 22     2
LVEF, left ventricular ejection fraction on echocardiogram; APACHE II, acute physiology and chronic health evaluation II; COPD, chronic obstructive pulmonary disease.
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Fig. 2. Kaplan-Meier survival curve shows significant difference in cumulative surviv-
al between two groups divided by APACHE II score 20. 
  The prospective study comparing the characteristics, clinical 
factors and prognosis according to the threshold score of APACHE 
II score 20 should be performed, to confirm that it would be high 
sensitive and specific standard in predicting prognosis. The proper 
echocardiographic and cardiac marker follow-up should be 
considered, to make sure that the cardiac function and myocar-
dial damages are not related to the prognosis of SIC. Given the 
small size of our study population, larger, prospective long-term 
observational studies are needed to confirm and validate these 
findings.
  The APACHE II score is higher in SIC patients who was dead, 
and the score of greater than 20, rather than cardiac function, is 
associated with mortality. It is able to give more information to 
physicians, regarding to the prognosis of SIC patients. 
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